Safety study of SSS55 in healthy volunteers
This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 45 years old
- In good general health with no serious medical conditions
- BMI between 19 and 28, with a minimum weight of 50 kg (men) or 45 kg (women)
- Must be willing to receive two vaccines (meningococcal and pneumococcal) at least 14 days before the study starts
- No history of drug or food allergies, recurrent infections, or recent use of antibiotics
- No active infections like hepatitis B or C, HIV, or syphilis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy volunteers to see how safe it is and how the body handles it. You will need to have had certain vaccines (meningitis and pneumonia) before joining, and you must be in generally good health.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This study tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. It is an early-phase trial, so it helps find the right dose and check for side effects.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.